<DOC>
	<DOC>NCT02718079</DOC>
	<brief_summary>The study will be conducted on patients admitted to Department of Hepatology from Jan 2016 to Jan 2018 at Institute of Liver &amp; Biliary Sciences, New Delhi. Study group will comprise of patients with acute liver failure (ALF) who have no option for liver transplant (due to any reason) or have contraindications for liver transplant or have no prospective living donor and will be assessed for enrollment in the trial.</brief_summary>
	<brief_title>High-Volume Plasma Exchange Versus Fractional Plasma Separation and Adsorption (Prometheus) in Patients With Acute Liver Failure</brief_title>
	<detailed_description />
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Liver Failure, Acute</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics, Antitubercular</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>Patients with acute liver failure defined as : Patients with jaundice which is complicated by encephalopathy and coagulopathy within 4 weeks of the onset of jaundice and without underlying chronic liver disease. Age &lt;12 or &gt; 75 years HepatoCellular Carcinoma Active untreated Sepsis/DIC Any evidence of active bleed secondary to coagulopathy Hemodynamic instability requiring high dose of Vasopressors Coma of nonhepatic origin. Pregnancy Comorbidities associated with poor outcome (Extrahepatic neoplasia, severe cardiopulmonary disease defined by a New York Heart Association score &gt;3, or oxygen/steroiddependent chronic obstructive pulmonary disease). Patients being taken up for liver transplant Refusal to participate in the study.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>